.
  • NIFTY 25,342.75 +167.35 (+0.66%)
  • SENSEX 82,344.68 +487.20 (+0.60%)
BSE
NSE

Wednesday, January 28, 2026 , BSE Sensex : 82,344.68 82,344.68(0.60%) , Adani Ports : 1,381.60 1,381.60(1.28%) , Asian Paints : 2,510.85 2,510.85(-4.34%) , Axis Bank : 1,320.50 1,320.50(0.46%) , Bajaj Finance : 935.15 935.15(2.20%) , Bajaj Finserv : 1,941.10 1,941.10(1.33%) , Bharat Electron : 453.40 453.40(8.90%) , Bharti Airtel : 1,957.05 1,957.05(-0.74%) , Eternal : 266.45 266.45(5.09%) , HCL Technologies : 1,730.40 1,730.40(0.61%) , HDFC Bank : 932.65 932.65(0.63%) , Hind. Unilever : 2,380.35 2,380.35(-0.83%) , ICICI Bank : 1,367.40 1,367.40(0.30%) , Infosys : 1,666.40 1,666.40(-1.01%) , Interglobe Aviat : 4,748.45 4,748.45(-0.44%) , ITC : 321.25 321.25(0.77%) , Kotak Mah. Bank : 412.40 412.40(0.84%) , Larsen & Toubro : 3,793.65 3,793.65(0.10%) , M & M : 3,448.65 3,448.65(1.60%) , Maruti Suzuki : 14,876.80 14,876.80(-2.39%) , NTPC : 348.20 348.20(0.88%) , Power Grid Corpn : 259.75 259.75(2.10%) , Reliance Industr : 1,397.05 1,397.05(1.16%) , SBI : 1,062.80 1,062.80(0.94%) , Sun Pharma.Inds. : 1,610.15 1,610.15(-1.78%) , Tata Steel : 193.80 193.80(0.68%) , TCS : 3,199.85 3,199.85(1.31%) , Tech Mahindra : 1,762.45 1,762.45(0.99%) , Titan Company : 3,976.70 3,976.70(-0.50%) , Trent : 3,863.30 3,863.30(1.91%) , UltraTech Cem. : 12,769.25 12,769.25(1.41%) ,

Nifty 50 : 25,342.75 167.35(0.66%) , Adani Enterp. : 1,994.70 35.20(1.80%) , Adani Ports : 1,381.90 18.00(1.32%) , Apollo Hospitals : 6,877.50 84.00(1.24%) , Asian Paints : 2,511.80 -111.00(-4.23%) , Axis Bank : 1,319.80 4.00(0.30%) , Bajaj Auto : 9,433.50 -58.50(-0.62%) , Bajaj Finance : 935.15 20.45(2.24%) , Bajaj Finserv : 1,940.30 22.60(1.18%) , Bharat Electron : 453.00 37.05(8.91%) , Bharti Airtel : 1,957.70 -15.70(-0.80%) , Cipla : 1,328.40 15.40(1.17%) , Coal India : 444.05 21.15(5.00%) , Dr Reddy's Labs : 1,222.50 -17.30(-1.40%) , Eicher Motors : 7,071.00 -93.50(-1.31%) , Eternal : 266.30 12.45(4.90%) , Grasim Inds : 2,839.10 -17.10(-0.60%) , HCL Technologies : 1,729.60 9.40(0.55%) , HDFC Bank : 932.70 6.30(0.68%) , HDFC Life Insur. : 728.60 8.55(1.19%) , Hind. Unilever : 2,378.40 -22.50(-0.94%) , Hindalco Inds. : 998.20 36.35(3.78%) , ICICI Bank : 1,367.70 6.30(0.46%) , Infosys : 1,666.50 -16.20(-0.96%) , Interglobe Aviat : 4,749.00 -20.00(-0.42%) , ITC : 321.15 2.50(0.78%) , Jio Financial : 255.20 -0.85(-0.33%) , JSW Steel : 1,218.70 -3.30(-0.27%) , Kotak Mah. Bank : 412.40 3.70(0.91%) , Larsen & Toubro : 3,794.00 6.20(0.16%) , M & M : 3,449.20 55.70(1.64%) , Maruti Suzuki : 14,877.00 -368.00(-2.41%) , Max Healthcare : 958.60 -16.90(-1.73%) , Nestle India : 1,292.40 -10.90(-0.84%) , NTPC : 348.05 3.35(0.97%) , O N G C : 268.58 20.63(8.32%) , Power Grid Corpn : 259.80 5.45(2.14%) , Reliance Industr : 1,396.70 16.20(1.17%) , SBI : 1,063.50 10.35(0.98%) , SBI Life Insuran : 2,053.20 15.00(0.74%) , Shriram Finance : 1,018.80 17.75(1.77%) , Sun Pharma.Inds. : 1,610.60 -28.30(-1.73%) , Tata Consumer : 1,131.80 -55.60(-4.68%) , Tata Motors PVeh : 340.45 -0.10(-0.03%) , Tata Steel : 193.85 1.57(0.82%) , TCS : 3,200.10 42.10(1.33%) , Tech Mahindra : 1,762.90 17.80(1.02%) , Titan Company : 3,975.20 -21.80(-0.55%) , Trent : 3,864.00 68.90(1.82%) , UltraTech Cem. : 12,767.00 178.00(1.41%) , Wipro : 237.35 2.55(1.09%) , Wednesday, January 28, 2026

Home >> Markets >> Equities >> News - News Details
Hot Pursuit
22-Jan-2026     10:09
Zydus Lifesciences rises after launching nivolumab biosimilar
The product is available in 100 mg and 40 mg strengths, priced at Rs 28,950 and Rs 13,950 respectively. The company said the prices are approximately one-fourth of the reference drug.

According to the company, the lower pricing is expected to improve affordability and reduce the overall cost of immunotherapy, with potential benefits for more than 5 lakh patients. The availability of two dosage strengths is intended to help clinicians optimise dosing and minimise drug wastage, which is a key cost factor in immuno-oncology treatments.

Zydus stated that Tishtha has been developed and manufactured in India, with an emphasis on ensuring consistent and long-term availability for patients who require therapy over multiple treatment cycles. The company highlighted affordability, consistency of supply, and reach as critical factors influencing access to modern cancer therapies.

Zydus Lifesciences is a global life sciences company with operations across pharmaceuticals, consumer wellness, and medical technology. It posted a 38.12% YoY rise in consolidated net profit to Rs 1,258.6 crore in Q2 FY26, while revenue grew 18.07% to Rs 6,037.9 crore.

Powered by Capital Market - Live News